Coriolis Experts Speak at Colorado Protein Stability Conference
The Colorado Protein Stability Conference 2022
Protein stability is important in numerous disciplines, ranging from fundamental and applied protein biophysics to basic and medical biochemistry to pharmaceutical sciences. However, it is rare that researchers from all of the relevant areas can join together to discuss the critical issues in the field in a more relaxed setting. Since 1994, Colorado Protein Stability Conferences have provided unique opportunities for this exchange of information. The topics that will be covered during 2022 Conference include: protein structure, thermodynamic stability, folding, and dynamics; stability of AAV vectors; amyloidosis and protein aggregation; engineering protein therapeutics; protein-excipient interactions; characterization of protein particles and new advances in processing of therapeutic proteins.
The scientific sessions will consist of plenary lectures by leading researchers from both academia and pharmaceutical industry. In addition, contributed papers will be presented during a half-day poster session with ample opportunities for young investigators to network and discuss their research. To foster exchange of information, attendance will be limited to the first 200 registrants.
This year, the conference will take place from 8 - 11 August in the Beaver Run Resort and Conference Center in Breckenridge, Colorado.
Coriolis will be participating with many exciting scientific talks
Dr. Michael Wiggenhorn, Member Board of Directors, will be present at the event and will host the Coriolis booth.
Our CSO Dr. Andrea Hawe will be chairing the session "Protein - Excipient Interactions" and our CTO Dr. Tim Menzen will give a talk about the "Analysis of particles in biopharmaceuticals: Case studies from protein-, virus-, and cells-based products".
Also, three of our scientific advisors will be presenting at the conference: Prof. Susumu Uchiyama, Osaka University - "Biophysical characterizations and stability assessment of AAV vectors for gene therapy", Prof. Hristo Svilenov, Ghent University - "The ABC’s of making stable antibodies with ultra-long complementarity-determining regions" and Prof. Wolfgang Friess, Ludwig-Maximilians University - "Proteins on the rack; protein particle formation upon peristaltic pumping"
All our experts are approachable throughout the event and are looking forward to many engaging talks and fruitful discussions.